EUVIMEDEUVIMED entdecken
Crossref

Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry Study

Julia J Shi, Krithi Meduri, Chien-Yi Liao, Dominic H Moon, Vladimir Avkshtol, David Parsons, Xinran Zhong, Liyuan Chen, Mu-Han Lin, David J Sher

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.03.050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Julia J Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Radiotherapy Planning, Computer-Assisted, Head and Neck Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Varian Medical Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Data are limited on the feasibility and dosimetric advantages of cone beam computed tomography-based online adaptive radiation therapy (oART) in head and neck squamous cell carcinoma. In this retrospective analysis, we assessed the dosimetric outcomes in patients receiving definitive radiation therapy and treated with oART at least once during their treatment course. METHODS AND MATERIALS: We retrospectively analyzed 69 patients with head and neck squamous cell carcinoma who received definitive-intent treatment and oART using the Varian Ethos system at a single tertiary care institution between September 2021 and March 2024. Dosimetric outcomes were compared using a t test. The coverage and mean doses of the planning target volumes (PTVs) and the dose to organs-at-risk (OARs) was analyzed. Conformality and heterogeneity were compared with the conformality index, maximum hotspot, and the absolute volume receiving 103%, 105%, and 107% of the maximum prescribed dose. Treatment delivery time was also recorded for each fraction. RESULTS: The cohort was primarily comprised of patients diagnosed with oropharynx (n = 46, 66.7%) and larynx/hypopharynx (n = 15, 21.7%) cancers. Adapted plans had significantly improved coverage when using the V100 as the coverage metric (95.83% vs 89.58%, P < .001) for all PTVs and improved D95% (99.63% vs 95.69%, P < .001) and D99% (95.64% vs 87.82%, P < .001) of the PTV70. The adapted plans also had a substantially smaller volume receiving above 103% of the prescription (-19.04 cc, P = .007). There was no significant difference in the dose distributions of any salivary glands, and the differences in other OARs were clinically insignificant. The mean total adaptive workflow time was 17 (SD, 1.9) minutes, and the mean total in-room time was 36 minutes (SD, 2.3 minutes). CONCLUSIONS: Online ART is associated with significantly improved coverage and dose homogeneity but not superior OAR sparing. Additional research is needed to optimally select patients for oART and determine the clinical benefits of these dosimetric advantages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckRadiotherapy Planning, Computer-AssistedHead and Neck NeoplasmsHumansOrgans at RiskCone-Beam Computed TomographyMaleFemaleRetrospective StudiesRadiotherapy DosageMiddle AgedAgedRegistriesAdultRadiotherapy, Intensity-ModulatedAged, 80 and overProspective Studies

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: david.sher@utsouthwestern.edu.

Förderung

  • Varian Medical Systems

Zitieren

APA

Shi, J. J., Meduri, K., Liao, C. Y., Moon, D. H., Avkshtol, V., Parsons, D., Zhong, X., Chen, L., Lin, M. H., & Sher, D. J. (2025). Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry Study. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.03.050

Vancouver

Shi JJ, Meduri K, Liao CY, Moon DH, Avkshtol V, Parsons D, et al. Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry Study. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.03.050

BibTeX
@article{Shi2025,
  author = {Shi, Julia J and Meduri, Krithi and Liao, Chien-Yi and Moon, Dominic H and Avkshtol, Vladimir and Parsons, David and Zhong, Xinran and Chen, Liyuan and Lin, Mu-Han and Sher, David J},
  title = {Dosimetric Advantages of Online Adaptive Radiation Therapy for Head and Neck Squamous Cell Carcinoma: Results From a Prospective Registry Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.03.050}
}
Kostenlos starten →